Canvas Wealth Advisors LLC Increases Stock Position in The Clorox Company $CLX

Canvas Wealth Advisors LLC lifted its stake in The Clorox Company (NYSE:CLX) by 17.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 34,788 shares of the company’s stock after acquiring an additional 5,240 shares during the quarter. Clorox accounts for about 0.8% of Canvas Wealth Advisors LLC’s investment portfolio, making the stock its 26th largest holding. Canvas Wealth Advisors LLC’s holdings in Clorox were worth $4,286,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in shares of Clorox by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after buying an additional 272,420 shares during the period. Invesco Ltd. increased its position in Clorox by 138.3% during the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock valued at $389,648,000 after acquiring an additional 1,883,465 shares during the last quarter. Norges Bank purchased a new stake in Clorox during the second quarter valued at $190,429,000. Arrowstreet Capital Limited Partnership lifted its holdings in Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after acquiring an additional 856,873 shares during the period. Finally, ProShare Advisors LLC boosted its position in Clorox by 7.0% in the second quarter. ProShare Advisors LLC now owns 1,160,881 shares of the company’s stock worth $139,387,000 after purchasing an additional 75,514 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the transaction, the director owned 13,000 shares in the company, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.6%

Shares of CLX stock opened at $119.52 on Friday. The Clorox Company has a 52-week low of $96.66 and a 52-week high of $159.04. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.50 and a current ratio of 0.74. The firm has a market capitalization of $14.45 billion, a PE ratio of 19.53, a PEG ratio of 0.58 and a beta of 0.59. The stock has a fifty day simple moving average of $105.83 and a two-hundred day simple moving average of $113.86.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the firm earned $1.55 earnings per share. Clorox’s revenue was down .8% on a year-over-year basis. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. Clorox’s dividend payout ratio (DPR) is presently 81.05%.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target on CLX to $136 (maintained equal-weight), citing valuation/earnings dynamics — a catalyst supporting the stock’s rally. Clorox (NYSE:CLX) Price Target Raised to $136.00 at Morgan Stanley
• Positive Sentiment: Investor write-ups are bullish: a Seeking Alpha piece frames CLX as a defensive, dividend-rich value after “solid” Q2 results and attractive valuation — supporting buy interest from income-focused investors. Clorox: Solid Q2 Results And Cheap Valuation MakesThis Defensive Dividend Stock A Strong Buy
• Neutral Sentiment: TD Cowen nudged its price target to $111 and kept a Hold rating — a modest recalibration that tempers upside expectations despite the recent positive headlines. TD Cowen Adjusts Clorox Price Target
• Neutral Sentiment: Company reported mixed Q2 results and reaffirmed its 2026 outlook — revenue roughly flat year-over-year and an EPS miss by a few cents; reassurances on the outlook limit downside but leave questions on near-term margin recovery. Clorox Posts Mixed Q2 Results, Reaffirms 2026 Outlook
• Neutral Sentiment: Management is weighing a potential GOJO acquisition and finishing an ERP implementation; strategic moves could boost long-term growth but add execution risk in the near term. Clorox Weighs GOJO Deal And ERP Finish Against Softer Earnings
• Neutral Sentiment: Q2 earnings call transcript is available for deeper read on management commentary around pricing, cost savings and margin plans — useful for gauging execution risk. Clorox (CLX) Q2 2026 Earnings Call Transcript
• Negative Sentiment: Some brokerages have a consensus “Reduce” rating on CLX, which may cap upside as institutional flows react to conservative guidance and margin concerns. The Clorox Company Given Consensus Rating of “Reduce” by Brokerages
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 EPS miss — a reminder that cost and margin recovery, not just revenue, will drive forecast revisions and investor sentiment. BofA Flags Margin Uncertainty for Clorox After Q2 Earnings Miss
• Neutral Sentiment: A Zacks piece highlights using its Earnings ESP tool to find staples stocks that might beat — general market research, not CLX-specific guidance, but could affect short-term trading interest. Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

Analysts Set New Price Targets

Several research firms have recently commented on CLX. BNP Paribas Exane reduced their price target on shares of Clorox from $103.00 to $101.00 and set an “underperform” rating for the company in a research report on Friday, January 16th. Wells Fargo & Company upped their target price on shares of Clorox from $108.00 to $115.00 and gave the company an “equal weight” rating in a report on Friday, January 23rd. TD Cowen increased their price target on shares of Clorox from $108.00 to $111.00 and gave the stock a “hold” rating in a research report on Wednesday. JPMorgan Chase & Co. upped their price objective on Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Royal Bank Of Canada set a $132.00 target price on Clorox in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, Clorox has an average rating of “Reduce” and a consensus price target of $117.93.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.